These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19649836)

  • 1. High-throughput toxicology: practical considerations.
    Robertson DG; Bulera SJ
    Curr Opin Drug Discov Devel; 2000 Jan; 3(1):42-7. PubMed ID: 19649836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity.
    Mortishire-Smith RJ; Skiles GL; Lawrence JW; Spence S; Nicholls AW; Johnson BA; Nicholson JK
    Chem Res Toxicol; 2004 Feb; 17(2):165-73. PubMed ID: 14967004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging technologies for accelerated toxicity evaluation of potential drug candidates.
    Todd MD; Ulrich RG
    Curr Opin Drug Discov Devel; 1999 Jan; 2(1):58-68. PubMed ID: 19649918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive toxicology in drug discovery--second international conference. New technologies for predicting toxic responses at an early stage. 10-11 November 1999, New Orleans, LA, USA.
    Tugwood J
    IDrugs; 2000 Feb; 3(2):179-81. PubMed ID: 16107935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IBC's Drug Discovery Technology - Europe 2001. 23-26 April 2001, Stuttgart, Germany.
    Kubinyi H
    IDrugs; 2001 Jul; 4(7):776-82. PubMed ID: 15995933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro to in vivo concordance of a high throughput assay of bone marrow toxicity across a diverse set of drug candidates.
    Olaharski AJ; Uppal H; Cooper M; Platz S; Zabka TS; Kolaja KL
    Toxicol Lett; 2009 Jul; 188(2):98-103. PubMed ID: 19446241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabonomics: a platform for studying drug toxicity and gene function.
    Nicholson JK; Connelly J; Lindon JC; Holmes E
    Nat Rev Drug Discov; 2002 Feb; 1(2):153-61. PubMed ID: 12120097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive toxicogenomics in preclinical discovery.
    Barros SA; Martin RB
    Methods Mol Biol; 2008; 460():89-112. PubMed ID: 18449484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of biomarkers in toxicity treatment "metabonomics" as a new biomarker discovery method].
    Naraoka H; Suzumura K; Takeuchi K; Sasayama T
    Rinsho Byori; 2008 Apr; 56(4):335-42. PubMed ID: 18516969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput screening for lead optimization: a rational approach.
    Bajpai M; Adkison KK
    Curr Opin Drug Discov Devel; 2000 Jan; 3(1):63-71. PubMed ID: 19649839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impacts of modern biology on drug discovery].
    Guo JB; Li XJ
    Sheng Li Ke Xue Jin Zhan; 2007 Jan; 38(1):25-31. PubMed ID: 17438949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug selection in early drug development: screening for acceptable pharmacokinetic properties using combined in vitro and computational approaches.
    Sinko PJ
    Curr Opin Drug Discov Devel; 1999 Jan; 2(1):42-8. PubMed ID: 19649916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow NMR spectroscopy in drug discovery.
    Stockman BJ
    Curr Opin Drug Discov Devel; 2000 May; 3(3):269-74. PubMed ID: 19649858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective.
    Buckley LA; Dorato MA
    Regul Toxicol Pharmacol; 2009 Aug; 54(3):301-7. PubMed ID: 19477212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular biosensing: chemical and genetic approaches.
    Haruyama T
    Anal Chim Acta; 2006 May; 568(1-2):211-6. PubMed ID: 17761262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-speed HPLC/MS/MS analysis of biological fluids: a practical review.
    Brockman AH; Hiller DL; Cole RO
    Curr Opin Drug Discov Devel; 2000 Jul; 3(4):432-8. PubMed ID: 19649874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose response considerations in risk assessment--an overview of recent ILSI activities.
    Holsapple MP; Wallace KB
    Toxicol Lett; 2008 Aug; 180(2):85-92. PubMed ID: 18588961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Looking forward in pharmaceutical process chemistry.
    Davies IW; Welch CJ
    Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.